Ivana Nikolic

Dr. Ivana Nikolic


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Journal of Hepatology
Verified
Journal Article
Closed access
VVVladislav Volarevic
Vladislav Volarevic
MMMarina Mitrovic
Marina Mitrovic
MMMarija Milovanovic
Marija Milovanovic
IZIvanka Zelen
Ivanka Zelen
INIvana Nikolic
Ivana Nikolic
MLMiodrag L. Lukic
Miodrag L. Lukic

1 August 2017 in Cytokine
Verified
Journal Article
Closed access
Dejan BaskicDejan Baskic
Dejan Baskic
VVVuk R. Vukovic
Vuk R. Vukovic
Suzana Lj. PopovićSuzana Lj. Popović
Suzana Lj. Popović
PDPredrag Djurdjevic
Predrag Djurdjevic
MZMilan Zaric
Milan Zaric
ZMZeljko Mijailovic
Zeljko Mijailovic

1 February 2015 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
DSDanijela Lj Stojković
Danijela Lj Stojković
VJVerica V. Jevtić
Verica V. Jevtić
GRGordana P. Radić
Gordana P. Radić
DTDanijela Todorovic
Danijela Todorovic
MPMarija Petrović
Marija Petrović
STSrećko R. Trifunović
Srećko R. Trifunović

16 January 2015 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MZMilan Zaric
Milan Zaric
MMMarina Mitrovic
Marina Mitrovic
INIvana Nikolic
Ivana Nikolic
DBDejan Baskic
Dejan Baskic
Suzana Lj. PopovićSuzana Lj. Popović
Suzana Lj. Popović
IZIvanka Zelen
Ivanka Zelen
Chronic lymphocytic leukemia (CLL) develops due to an imbalance between apoptosis and proliferation of B lymphocytes. Chrysin induced apoptosis in leukemia cell lines such as U937, MO7e, THP-1 and HL-60, but there has not yet been data demonstrating the apoptotic effect of chrysin on CLL cells. Therefore, in our investigation we examined the cytotoxicity of chrysin against two leukemia cell lines, MOLT-4 and JVM-13, peripheral blood lymphocytes isolated from B-CLL patients and peripheral blood mononuclear cells (PBMC) from healthy individuals in vitro. The effect of chrysin on viability of MOLT-4 and JVM-13 cell lines, B-CLL cells derived from 28 patients and PBMC from 16 healthy subjects was determined by MTT assay. The type of cell death induced by chrysin was verified by Annexin V/7AAD assay and acridine orange and ethidium bromide (AO/EB) staining assay. Intracellular localisation and endogenic expression of apoptotic proteins including Bax, Bcl-2, cytochrome c and caspase-3 were determined by flow cytometry and fluorescent microscopy. Our results demonstrated that exposure of MOLT-4, JVM-13 cell lines and B-CLL cells to the concentration of chrysin of 10μM and higher selectively decreased viability of cells in this cell population, but not in the PBMC derived from healthy subjects; LC50 values of chrysin for B-CLL cells were 51μM for 24 hours and 32μM for 48 hours of incubation, respectively. Our findings demonstrated that chrysin induces the activation of proapoptotic Bax and decreases the expression of antiapoptotic Bcl-2 protein, releases cytochrome c from mitochondria into cytosol and cleavages/activates caspase-3, subsequently leading to the activation of apoptosis of B-CLL cells. Together, these findings suggest that chrysin selectively induces apoptosis of peripheral blood lymphocytes isolated from human chronic lymphocytic leukemia patients via mitochondrial pathway in vitro and that it might have a promising role as a potential future antileukemic remedy.

1 January 2017 in Archives of Medical Science
Verified
Journal Article
Open access
INIvana Nikolic
Ivana Nikolic
MAMarija Andjelkovic
Marija Andjelkovic
MZMilan Zaric
Milan Zaric
IZIvanka Zelen
Ivanka Zelen
PCPetar Predrag Canovic
Petar Predrag Canovic
MMMarina Mitrovic
Marina Mitrovic
Introduction: Endometrial hyperplasia is a condition that occurs as a result of hormonal imbalance between estrogen and progesterone. Morphological disturbance of endometrial cells occurs consequently leading towards endometrial cancer. In therapy of endometrial hyperplasia SERMs are used to...

29 February 2020 in Acta Poloniae Pharmaceutica - Drug Research
Verified
Journal Article
Open access
JLJovan Luković
Jovan Luković
MMMarina Mitrović
Marina Mitrović
SPSuzana Popović
Suzana Popović
ZMZoran Milosavljević
Zoran Milosavljević
MSMarijana Stanojević-Pirković
Marijana Stanojević-Pirković
INIvana Nikolic
Ivana Nikolic